当前位置： SCI文献检索 > ANTICANCER RESEARCH期刊下所有文献 > Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.

Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.

Abstract：

BACKGROUND:Several studies have demonstrated the efficacy of systemic oxaliplatin (Oxa) in combination with 5-fluorouracil (5-FU) and folinic acid (FA) for the treatment of colorectal liver metastases (CRLM). However, nothing is presently known about the pharmacokinetics of Oxa administered via the hepatic artery and only very little about the feasibility and toxicity of Oxa used for hepatic artery infusion (HAI). PATIENTS AND METHODS:We designed a phase II trial using Oxa in combination with 5-FU/FA and mitomycin C (MMC) for HAI treatment of patients with isolated non-resectable CRLM. Oxa (130 mg/m2) was delivered on day (d) 1 as a 120-min infusion followed by FA (140 mg/m2) for 10 min and 5-FU (480 mg/m2) for 120 min from d1 to d5 and MMC (7 mg/m2) for 30 min on d5 every 35 days. For Oxa pharmacokinetics, peripheral venous blood was collected before, during and after arterial infusion. Oxaliplatin was determined by liquid chromatography with post-column derivatization in blood ultra filtrate. RESULTS:A total of 33 HAI cycles were administered to 5 patients with tolerable toxicity, which mainly consisted of grade I and II nausea, vomiting, leucopenia, thrombopenia and abdominal pain. During 4 cycles nausea/vomiting III degree occurred, during 3 cycles diarrhoea and abdominal pain III degree. No neurotoxicity > or = II degree and no catheter occlusion was observed. Staging showed 4 PR and 1 PD. Pharmacokinetic analysis revealed an AUC value of 85.3 micrograms x min/ml after HAI. Recalculating these values with the previously reported AUC value for systemic administration (161 micrograms x min/ml) revealed a liver extraction ratio of 0.47 for Oxa. CONCLUSION:We conclude from our results that Oxa in combination with 5-FU/FA and MMC may be a feasible protocol for HAI treatment without major toxicity, especially avoiding higher grade neurotoxicity. This is probably attributable to the low systemic bioavailability of Oxa.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Guthoff I,Lotspeich E,Fester C,Wallin I,Schatz M,Ehrsson H,Kornmann M

subject

Has Abstract

pub_date

2003-11-01 00:00:00

pages

5203-8

issue

6D

eissn

0250-7005

issn

1791-7530

journal_volume

23

pub_type

临床试验,杂志文章

相关文献

ANTICANCER RESEARCH文献大全
  • The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.

    abstract：:Constitutive activation of signal transducer and activator of transcription 3 (STAT3) has been indicated as a novel cancer drug target, since it plays an important role in diverse oncogenic processes including survival, cell proliferation and migration. Emerging STAT3 inhibitors have demonstrated efficacy in cancer ce...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.11347

    authors： Tian J,Xiao H,Wu R,Cao Y,Li C,Xu R,Pierson CR,Finlay JL,Yang F,Gu N,Lin J

    更新日期：2017-02-01 00:00:00

  • Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance.

    abstract：:In this study the unexpected findings from the analysis of 278 breast cancer tissue specimens are reported. A surprising strongly positive correlation between an unfavourable and a favourable prognosis with markers cathepsin D and pS2 respectively, was revealed by linear regression analysis (Pearson, Student-T-Test). ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Ardavanis A,Gerakini F,Amanatidou A,Scorilas A,Pateras C,Garoufali A,Pissakas G,Stravolemos K,Apostolikas N,Yiotis I

    更新日期：1997-09-01 00:00:00

  • Does pulmonary resection promote the progression of unresected ground-glass nodules?

    abstract：BACKGROUND:The routine use of thin-section, whole-lung computed tomographic scanning helps detect persistent ground-glass nodules (GGNs) co-existing with the target lesion in the underlying lung. PATIENTS AND METHODS:The cases of 10 patients with persistent co-existing GGNs detected on whole-lung computed tomography p...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Ueda K,Sano F,Murakami J,Hayashi M,Kobayashi T,Kunihiro Y,Hamano K

    更新日期：2014-12-01 00:00:00

  • Identification, Molecular Characterization and Alternative Splicing of Three Novel Members of the Canine Kallikrein (Klk)-related Peptidase Family.

    abstract：BACKGROUND/AIM:Kallikrein-related peptidases (KLKs) comprise a serine protease family with prominent roles in tissue physiology and disease pathogenesis, including cancer. Previously, we have characterized canine Klk4-10 and -14. Herein, we continue our efforts by characterizing three novel members of the canine family...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Angelopoulou K,Karagiannis GS

    更新日期：2015-05-01 00:00:00

  • Influence of culture media and multidrug resistance on the wheat germ agglutinin (WGA) glycocytochemical expression of two human glioblastoma cell lines.

    abstract：:Over the last two decades, many studies carried out with the aid of lectins have firmly established that cell glycans usually change in the course of the normal processes of growth and development, as well as in pathological situations. We describe here the in vivo binding expression of wheat germ agglutinin (WGA) to ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Camby I,Salmon I,Rombaut K,Pasteels JL,Kiss R,Danguy A

    更新日期：1996-07-01 00:00:00

  • Prognostic Influence of the Extent of Lymph Node Dissection and Perioperative Comorbidities in Patients with Gastric Cancer.

    abstract：BACKGROUND:The proportion of geriatric gastric cancer (GC) patients with comorbidities has been increasing in Japan. This study was designed to evaluate the prognostic influence of the extent of lymph node dissection (END) and perioperative morbidities in patients with GC. PATIENTS AND METHODS:Between 2008 and 2013, t...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Kawaguchi T,Komatsu S,Ichikawa D,Kimura YU,Komiyama S,Konishi H,Kin S,Kawakami S,Kosuga T,Okamoto K,Otsuji E

    更新日期：2016-04-01 00:00:00

  • Prediction of Early Recurrence After Curative Resection of Colorectal Liver Metastasis and Subsequent S-1 Chemotherapy.

    abstract：BACKGROUND:S-1, an oral 5-fluorouracil (5-FU)-based medicine that combines tegafur, gimeracil and oteracil potassium is commonly used as an adjuvant chemotherapeutic drug for the treatment of colorectal cancer. PATIENTS AND METHODS:We enrolled 53 patients who underwent curative resection for colorectal cancer and live...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Yamauchi K,Kokuryo T,Yokoyama Y,Uehara K,Yamaguchi J,Nagino M

    更新日期：2016-05-01 00:00:00

  • PB-100: a potent and selective inhibitor of human BCNU resistant glioblastoma cell multiplication.

    abstract：:Major drawbacks to present-day cancer chemotherapy are its intrinsic lack of selectivity for tumour cells, resulting in severe damage to normal rapidly dividing cells, and the widespread emergence of drug resistance. Here experimental evidence is presented demonstrating that PB-100, a beta-carboline alkaloid, selectiv...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Beljanski M,Crochet S,Beljanski MS

    更新日期：1993-11-01 00:00:00

  • AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines.

    abstract：:BRCA1 acts as a tumour suppressor and germ-line mutations within this gene are found in a large proportion of families with breast cancer. The aim of our study was to unravel the mechanism of action of genistein, the major soy phytoestrogen, in BRCA1-mutant human breast cancer cell lines. Four breast cancer cell lines...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Privat M,Aubel C,Arnould S,Communal Y,Ferrara M,Bignon YJ

    更新日期：2010-06-01 00:00:00

  • Adjuvant interferon alpha therapy in renal cell carcinoma (RCC): prognostic value of DNA cytophotometry.

    abstract：BACKGROUND:Adjuvant immunotherapy with interferon alpha in non-metastatic RCC is still controversial. It was the aim of the present study to investigate whether tumor ploidy can help to isolate a group of patients profitting from this treatment. MATERIALS AND METHODS:Survival data of 119 patients undergoing tumor neph...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Basting R,Corvin S,Händel D,Hinke A,Schmidt D

    更新日期：1999-03-01 00:00:00

  • Pooled-analysis of Lipegfilgrastim Effectiveness and Safety Among Patients With Blood Malignancies in the Real-world Setting.

    abstract：BACKGROUND/AIM:The aim of this report was to summarize the real-world experience with lipegfilgrastim as a neutropenia prophylaxis in a large cohort of lymphoma patients receiving immuno-, chemo-therapy. PATIENTS AND METHODS:Observational clinical data were derived from two phase IV studies (NADIR and LEOS) with simil...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.14782

    authors： Pettengell R,Wolff T,Goehler T,Cascavilla N

    更新日期：2021-01-01 00:00:00

  • Association of liver steatosis with colorectal cancer and adenoma in patients with metabolic syndrome.

    abstract：AIM:Metabolic syndrome has been identified as a risk factor for colorectal cancer and adenoma. The aim of our study was to assess the risk of colorectal cancer and adenoma in an adult Italian population with metabolic syndrome. PATIENTS AND METHODS:Ninety patients with metabolic syndrome were prospectively compared ag...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Fiori E,Lamazza A,De Masi E,Schillaci A,Crocetti D,Antoniozzi A,Sterpetti AV,De Toma G

    更新日期：2015-04-01 00:00:00

  • Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.

    abstract：BACKGROUND:The presence of circulating tumor cells (CTCs) in the peripheral blood is a prerequisite for the formation of distant metastases. Transforming growth factor-βeta (TGF-β) and Chemokine (C-X-C Motif) Ligand-1 (CXCL1) are cytokines involved in the colonization of distant sites by CTCs in several pre-clinical an...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Divella R,Daniele A,Savino E,Palma F,Bellizzi A,Giotta F,Simone G,Lioce M,Quaranta M,Paradiso A,Mazzocca A

    更新日期：2013-04-01 00:00:00

  • Lobarstin enhances chemosensitivity in human glioblastoma T98G cells.

    abstract：BACKGROUND/AIM:Lobarstin is a metabolite occurring from the Antarctic lichen Stereocaulon alpnum. Human glioblastoma is highly resistant to chemotherapy with temozolomide. Lobarstin was examined for its effect on glioblastoma. MATERIALS AND METHODS:Temozolomide-resistant T98G cells were subjected to toxicity test with...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Kim S,Jo S,Lee H,Kim TU,Kim IC,Yim JH,Chung H

    更新日期：2013-12-01 00:00:00

  • Combination effect of equol and TRAIL against human cervical cancer cells.

    abstract：BACKGROUND/AIM:Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer therapy due to its selective ability to induce apoptosis of cancer cells. However, some cancer cells are resistant to TRAIL. Here, we demonstrated that treatment with TRAIL, in combination with equol, sens...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Kim EY,Kim AK

    更新日期：2013-03-01 00:00:00

  • Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.

    abstract：BACKGROUND:Tumorigenesis is a multistep process that begins with the abrogation of normal controls of apoptosis and cell proliferation, and the FAS receptor-ligand system is a key regulator of apoptosis. The aim of this study was to investigate whether functional polymorphisms of death pathway genes (FAS and FASL) are ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Hsu PI,Lu PJ,Wang EM,Ger LP,Lo GH,Tsay FW,Chen TA,Yang HB,Chen HC,Lin WS,Lai KH

    更新日期：2008-01-01 00:00:00

  • Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).

    abstract：BACKGROUND:Doxorubicin remains one of the few drugs with consistent single agent activity in advanced Soft Tissue Sarcomas (STS), with a demonstrated dose-response relationship. Liposomal-encapsulated Doxorubicin (LED) has been shown to be at least as active as free doxorubicin in experimental models, and phase I and I...

    journal_title：Anticancer research

    pub_type： 临床试验,杂志文章

    doi：

    authors： Toma S,Tucci A,Villani G,Carteni G,Spadini N,Palumbo R

    更新日期：2000-01-01 00:00:00

  • Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stages III/IV) non-Hodgkin's lymphoma.

    abstract：:Pegylated liposomal doxorubicin is associated with a lower risk of cardiotoxocity than conventional formulations of doxorubicin, allowing the use of higher cumulative doses. In this Phase II study, 25 patients aged over 70 years (median 79, range 75-82 years) with aggressive non-Hodgkin's lymphoma (NHL) (International...

    journal_title：Anticancer research

    pub_type： 临床试验,杂志文章,多中心研究

    doi：

    authors： Tsavaris N,Kosmas C,Vadiaka M,Giannouli S,Siakantaris MP,Vassilakopoulos T,Pangalis GA

    更新日期：2002-05-01 00:00:00

  • TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.

    abstract：:The vascular endothelium participates in angiogenesis, inflammation and the immune response, which are modulated by vasoactive cytokines such as tumour necrosis factor-alpha (TNF alpha) and transforming growth factor-beta 1 (TGF beta 1). CD105 is a component of the TGF beta receptor complex and is abundantly expressed...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Li C,Guo B,Ding S,Rius C,Langa C,Kumar P,Bernabeu C,Kumar S

    更新日期：2003-03-01 00:00:00

  • Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.

    abstract：BACKGROUND/AIM:Pancreatic neuroendocrine tumors (pNETs) are rare pancreatic neoplasms, and therapeutic options for pNETs are limited. Metformin is an anti-hypoglycemic drug that appears to have anticancer effects. However, little is known about the effect of metformin on pNETs. In this study, we investigated the anti-p...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.13933

    authors： Yamana H,Kato K,Kobara H,Fujihara S,Fujita K,Namima D,Fujita N,Kobayashi K,Kamada H,Morishita A,Tsutsui K,Iwama H,Masaki T

    更新日期：2020-01-01 00:00:00

  • PS2 expression in BRCA1-associated breast cancers.

    abstract：BACKGROUND:PS2-expression is controlled by estrogens and is a prognostic factor for long-term and post-relapse survival. Breast carcinomas associated with a BRCA1 mutation (BRCA1-BC'S) exhibit many specific features, particularly for ER expression. Our purpose was to determine if pS2-expression was different in BRCA1-B...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Charafe-Jauffre E,Eisinger F,Mathoulin-Portier MP,Sobol H,Jacquemier J

    更新日期：2001-07-01 00:00:00

  • Molecular "rehabilitation" by rational drug targeting: the challenge of P53 in cancer treatment.

    abstract：:The p53 tumor suppressor protein is a pivotal molecule in the protection against carcinogenesis and is inactivated in a plethora of human neoplasms, p53 prevents the accumulation of genomic alterations by inducing cell-cycle arrest or programmed cell death in response to genotoxic signals such as DNA damage and stress...

    journal_title：Anticancer research

    pub_type： 杂志文章,评审

    doi：

    authors： Tzatsos A,Papavassiliou AG

    更新日期：1999-09-01 00:00:00

  • Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy.

    abstract：:Metallopanstimulin (MPS) is a 9.5-kDal subunit "zinc finger" protein which is expressed in a wide variety of actively proliferating cells and tumor tissues (J. Biol. Chem. 268:21198-21204, 1993; Cell Growth & Diff. 5:811-825, 1994). A sensitive and specific radioimmunoassay (RIA) has been developed to measure circulat...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Fernandez-Pol JA

    更新日期：1996-07-01 00:00:00

  • Ultrastructural studies of interactions of B16 melanoma cells and normal mouse skin fibroblasts in the three-dimensional collagen gels in vitro.

    abstract：:In the in vivo system, cancer metastasis is a complex multi-step process. We have utilized an in vitro three-dimensional system to study the initial stages of tumour cell invasion. In this communication, the sequence of events in interactions between B16 melanoma cells and normal mouse skin fibroblasts are described. ...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Mok CH,Chew EC,Riches DJ

    更新日期：1986-09-01 00:00:00

  • The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study.

    abstract：:Glutathione (GSH) concentration is high in most tumour cells and this may be an important factor in resistance to chemotherapy. Previous in-vitro and animal experiments have shown a differential response of tumour versus normal cells to various cysteine delivery systems. More specifically, an in-vitro assay showed tha...

    journal_title：Anticancer research

    pub_type： 临床试验,杂志文章

    doi：

    authors： Kennedy RS,Konok GP,Bounous G,Baruchel S,Lee TD

    更新日期：1995-11-01 00:00:00

  • Comparison of Cold Atmospheric Plasma Devices' Efficacy on Osteosarcoma and Fibroblastic In Vitro Cell Models.

    abstract：BACKGROUND/AIM:Cold atmospheric plasma (CAP) attenuates tumor cell proliferation and induces apoptosis in various cell lines. While exerting marginal effects on non-neoplastic cells this unfolds promising applications in cancer therapy. The aim of the study was to analyse the effects of different CAP sources and applic...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：10.21873/anticanres.11968

    authors： Gümbel D,Suchy B,Wien L,Gelbrich N,Napp M,Kramer A,Ekkernkamp A,Daeschlein G,Stope MB

    更新日期：2017-10-01 00:00:00

  • Antisense p53 oligonucleotides inhibit proliferation and induce chemosensitivity in follicular thyroid cancer cells.

    abstract：BACKGROUND:The potential of MTp53 knockout by oligodesoxyribonucleotide phosphothioates (ODNs) to affect proliferation, apoptosis and chemosensitivity in undifferentiated thyroid cancer (UTC) cells with a recessive MTp53 mutation was evaluated. MATERIALS AND METHODS:Transient transfections with ODNs complementary to p...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Hassan I,Wunderlich A,Burchert A,Hoffmann S,Zielke A

    更新日期：2006-03-01 00:00:00

  • Inhibition of invasion of MCF-7/6 human breast carcinoma cells in vitro by Methanobacterium thermoautotrophicum extract.

    abstract：:Precultured embryonic chick heart fragments were confronted in vitro with various invasive tumor cell lines (MCF-7/6 human breast carcinoma variant, BW-O-LiI mouse T-cell lymphoma cells and MO4 virally transformed fetal mouse carcass cells) and with a non-invasive cell line (MCF-7/AZ human breast carcinoma variant). C...

    journal_title：Anticancer research

    pub_type： 杂志文章

    doi：

    authors： Raemakers-Franken PC,Bracke ME,Van Larebeke N,Vyncke B,Mareel MM

    更新日期：1992-03-01 00:00:00

  • Prognostic role of angiogenesis in colorectal cancer.

    abstract：:The need for dependable prognostic markers in colorectal cancer, both in the advanced as well the as adjuvant setting, is greater than ever. The introduction of new chemotherapeutic agents in the clinic, with different mechanisms of action as well as different side-effect profiles, has made this even more important. A...

    journal_title：Anticancer research

    pub_type： 杂志文章,评审

    doi：

    authors： Papamichael D

    更新日期：2001-11-01 00:00:00

  • Sequential versus concurrent chemo-radiotherapy in inoperable stage III non-small cell lung cancer.

    abstract：AIM:To define the best sequence of radiotherapy and chemotherapy for inoperable stage III non-small cell lung (NSCL) tumours. MATERIALS AND METHODS:A systematic review was performed on the clinical results of radiotherapy, combined or not with chemotherapy, for inoperable NSCL cancer stage III. The mean median surviva...

    journal_title：Anticancer research

    pub_type： 杂志文章,评审

    doi：

    authors： El-Sharouni SY,Kal HB,Battermann JJ,Schramel FM

    更新日期：2006-01-01 00:00:00